Previous Close | 4.0000 |
Open | 4.0500 |
Bid | 0.0000 x 0 |
Ask | 0.0000 x 0 |
Day's Range | 3.9000 - 4.0950 |
52 Week Range | 2.6600 - 4.7000 |
Volume | |
Avg. Volume | 20,785 |
Market Cap | 8.838M |
Beta (5Y Monthly) | 2.29 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -5.4400 |
Earnings Date | Oct 25, 2024 - Oct 28, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Mar 28, 2007 |
1y Target Est | N/A |
WOBURN, Mass., Aug. 13, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq: NURO) today for the purpose of clarity, reiterated that the Company is engaged in a review of strategic alternatives. In February of this year, the Company announced that it had initiated a review of strategic options with an objective of enhancing shareholder value. Over the past 6 months, the Company has invested considerable effort in evaluating a number of specific strategic directions and also making financial, oper
NeuroMetrix ( NASDAQ:NURO ) Second Quarter 2024 Results Key Financial Results Revenue: US$769.1k (down 54% from 2Q...